Ivey Business School (Canada)
-
Change at Pfizer: Jeff Kindler (C) Post Wyeth Acquisition Organization
Michael J. Rouse; Chander SehgalCase IVEY-9B10M054-EStrategyThis case is a supplement to Change at Pfizer: Jeff Kindler (A).Starting at €5.74
-
Change at Pfizer: Jeff Kindler (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M014-EStrategyPfizer Inc., the largest research-based drug company in the world, was faced with multiple challenges, including fierce court battles with generic drug companies over the patents of Lipitor, reduced productivity from research and development, and a changing external health care environment globally, with growing importance of emerging markets. These challenges were set within a business environment characterized by multi-level change and uncertai...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (B) The Wyeth Acquisition
Michael J. Rouse; Chander SehgalCase IVEY-9B10M053-EStrategyThis supplement to Change at Pfizer: Jeff Kindler (A) deals with Pfizer’s 2009 acquisition of Wyeth — the first mega-acquisition since the world economic crisis.Starting at €5.74
-
Alice’s Maternity Leave: Beneficial Leave or Left Behind?
John D. Varlaro; Nicole M. AmosCase IVEY-W25470-ELeadership and People ManagementAlice Moore worked remotely as a full-time senior data associate for Bloom Inc., a global technology firm in the United States. The department in which Moore worked was restructured while she was on maternity leave; yet despite having a strong performance record, Moore received neither a promotion nor a pay increase, while some colleagues did. She returned from her maternity leave in June 2018, and regardless of more than a year of emails and mee...Starting at €8.20